Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Ann Nucl Med. 2019 Feb 27;33(6):383–393. doi: 10.1007/s12149-019-01345-w

Table 3.

PFS and OS by PET response dichotomy based on SUVmean valuesb

Progression-free survival (PFS)
N Events Point estimate 80% Confidence interval
Lower limit Upper limit
Non-responders
 Median 7 5 3.7 years 0.3 years 11.6 years
  1-year rate 68% 40% 85%
  3-year rate 57% 29% 77%
  5-year rate 33% 12% 57%
  10-year rate 22% 6% 46%
Responders
 Median 9 5 7.9 years 0.0 years N/A
  1-year rate 70% 46% 85%
  3-year rate 63% 39% 79%
  5-year rate 58% 35% 76%
  10-year rate 42% 20% 65%
Overall survival (OS)
N Events Point estimate 80% Confidence interval
Lower limit Upper limit
Non-responders
 Median 7 4 5.0 years 0.0 years N/A
  1-year rate 70% 42% 86%
  3-year rate 63% 36% 81%
  5-year rate 51% 25% 71%
  10-year rate N/A N/A N/A
Responders
 Median 9 6 7.5 years 0.8 years 13.5 years
  1-year rate 88% 65% 96%
  3-year rate 64% 40% 80%
  5-year rate 59% 36% 76%
  10-year rate 39% 19% 60%

N/A not applicable

b

PFS progression-free survival, OS overall survival, PET positron emission tomography, SUVmean mean standardized uptake value, Events death for overall survival; death or progression for progression-free survival